Ocular allergy: The Third Annual Thygeson Lecture, presented at the Ocular Microbiology and Immunology Group Meeting, October 25, 1997

被引:2
作者
Smolin, G [1 ]
机构
[1] Univ Calif San Francisco, Francis I Proctor Fdn, San Francisco, CA 94143 USA
关键词
D O I
10.1097/00003226-199805000-00003
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
引用
收藏
页码:253 / 256
页数:4
相关论文
共 16 条
[1]   Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro [J].
Buscaglia, S ;
Paolieri, F ;
Catrullo, A ;
Fiorino, N ;
Riccio, AM ;
Pesce, G ;
Montagna, P ;
Bagnasco, M ;
Ciprandi, G ;
Canonica, GW .
CLINICAL AND EXPERIMENTAL ALLERGY, 1996, 26 (10) :1188-1196
[2]   Recombinant mite allergens - New technologies for the management of patients with asthma [J].
Chapman, MD ;
Smith, AM ;
Vailes, LD .
ALLERGY, 1997, 52 (04) :374-379
[3]   Antihistamines: Topical vs oral administration [J].
Davies, RJ ;
Bagnall, AC ;
McCabe, RN ;
Calderon, MA ;
Wang, JH .
CLINICAL AND EXPERIMENTAL ALLERGY, 1996, 26 :11-17
[4]  
EHLERS W H, 1992, CLAO Journal, V18, P117
[5]  
ELDEFRAWY S, 1996, NEW DRUGS OPHTHALMOL, P25
[6]  
Fujishima H, 1997, CLIN EXP ALLERGY, V27, P372
[7]  
Fujishima H, 1997, INVEST OPHTH VIS SCI, V38, P1350
[8]   HISTAMINE AND TRYPTASE LEVELS IN ALLERGIC CONJUNCTIVITIS AND VERNAL KERATOCONJUNCTIVITIS [J].
FUKAGAWA, K ;
SAITO, H ;
AZUMA, N ;
TSUBOTA, K ;
IIKURA, Y ;
OGUCHI, Y .
CORNEA, 1994, 13 (04) :345-348
[9]   THERAPEUTIC OPTIONS IN OCULAR ALLERGIC DISEASE [J].
HINGORANI, M ;
LIGHTMAN, S .
DRUGS, 1995, 50 (02) :208-221
[10]  
MYGIND N, 1996, ESSENTIAL ALLERGY, P9